{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:28:22Z","timestamp":1792618102472,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","award":["Postgraduate Research Scholarship"],"award-info":[{"award-number":["Postgraduate Research Scholarship"]}],"id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1174060"],"award-info":[{"award-number":["1174060"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["RM34909"],"award-info":[{"award-number":["RM34909"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A minimally invasive blood-based assessment of cognitive function could be a promising screening strategy to identify high-risk groups for the incidence of Alzheimer\u2019s disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 448 cognitively unimpaired men (mean age 64.1 years) drawn from the Geelong Osteoporosis Study. A targeted mass spectrometry-based proteomic assay was performed to measure the abundance levels of 269 plasma proteins followed by linear regression analyses adjusted for age and <jats:italic>APOE<\/jats:italic> \u03b54 carrier status to identify the biomarkers related to overall cognitive function. Furthermore, two-way interactions were conducted to see whether Alzheimer\u2019s disease-linked genetic variants or health conditions modify the association between biomarkers and cognitive function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten plasma proteins showed an association with overall cognitive function. This association was modified by allelic variants in genes <jats:italic>ABCA7<\/jats:italic>, <jats:italic>CLU<\/jats:italic>, <jats:italic>BDNF<\/jats:italic> and <jats:italic>MS4A6A<\/jats:italic> that have been previously linked to Alzheimer\u2019s disease. Modifiable health conditions such as mood disorders and poor bone health, which are postulated to be risk factors for Alzheimer\u2019s disease, also impacted the relationship observed between protein marker levels and cognition. In addition to the univariate analyses, an 11-feature multianalyte model was created using the least absolute shrinkage and selection operator regression that identified 10 protein features and age associated with cognitive function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, the present study revealed plasma protein candidates that may contribute to the development of a blood-based screening test for identifying early cognitive changes. This study also highlights the importance of considering other risk factors in elucidating the relationship between biomarkers and cognition, an area that remains largely unexplored.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-023-01294-7","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:02:56Z","timestamp":1693548176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A plasma protein signature associated with cognitive function in men without severe cognitive impairment"],"prefix":"10.1186","volume":"15","author":[{"given":"Kanika","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia X.","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Walder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Lung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer Bala","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"crossref","unstructured":"Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer\u2019s disease. Sci Adv. 2019;5:eaau7220.","DOI":"10.1126\/sciadv.aau7220"},{"key":"1294_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/mp.2013.40","volume":"19","author":"SC Burnham","year":"2014","unstructured":"Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, et al. A blood-based predictor for neocortical A\u03b2 burden in Alzheimer\u2019s disease: results from the AIBL study. Mol Psychiatry. 2014;19:519\u201326.","journal-title":"Mol Psychiatry."},{"key":"1294_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","volume":"69","author":"HD Soares","year":"2012","unstructured":"Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol. 2012;69:1310\u20137.","journal-title":"Arch Neurol."},{"key":"1294_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/ane.13628","volume":"146","author":"H Zetterberg","year":"2022","unstructured":"Zetterberg H, Schott JM. Blood biomarkers for Alzheimer\u2019s disease and related disorders. Acta Neurol Scand. 2022;146:51\u20135.","journal-title":"Acta Neurol Scand."},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejca.2019.11.021","volume":"127","author":"M Bhardwaj","year":"2020","unstructured":"Bhardwaj M, Weigl K, Tikk K, Holland-Letz T, Schrotz-King P, Borchers CH, et al. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. Eur J Cancer. 2020;127:30\u201340.","journal-title":"Eur J Cancer."},{"key":"1294_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/bmm.12.48","volume":"6","author":"C Bazenet","year":"2012","unstructured":"Bazenet C, Lovestone S. Plasma biomarkers for Alzheimer\u2019s disease: much needed but tough to find. Biomark Med. 2012;6:441\u201354.","journal-title":"Biomark Med."},{"key":"1294_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88:640\u201351.","journal-title":"Biochem Pharmacol."},{"key":"1294_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101575","volume":"76","author":"K Mehta","year":"2022","unstructured":"Mehta K, Thandavan SP, Mohebbi M, Pasco JA, Williams LJ, Walder K, et al. Depression and bone loss as risk factors for cognitive decline: a systematic review and meta-analysis. Ageing Res Rev. 2022;76:101575.","journal-title":"Ageing Res Rev."},{"key":"1294_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jad.2015.09.046","volume":"190","author":"D Gallagher","year":"2016","unstructured":"Gallagher D, Kiss A, Lanctot K, Herrmann N. Depressive symptoms and cognitive decline: a longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. J Affect Disord. 2016;190:235\u201340.","journal-title":"J Affect Disord."},{"key":"1294_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1017\/S0033291718001137","volume":"49","author":"A John","year":"2019","unstructured":"John A, Patel U, Rusted J, Richards M, Gaysina D. Affective problems and decline in cognitive state in older adults: a systematic review and meta-analysis. Psychol Med. 2019;49:353\u201365.","journal-title":"Psychol Med."},{"key":"1294_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00223-015-0102-6","volume":"98","author":"A Laudisio","year":"2016","unstructured":"Laudisio A, Fontana DO, Rivera C, Ruggiero C, Bandinelli S, Gemma A, et al. Bone mineral density and cognitive decline in elderly women: results from the InCHIANTI study. Calcif Tissue Int. 2016;98:479\u201388.","journal-title":"Calcif Tissue Int."},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1034\/j.1601-5215.2002.51007.x","volume":"51","author":"LY Lui","year":"2003","unstructured":"Lui LY, Stone K, Cauley JA, Hillier T, Yaffe K. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51:38\u201343.","journal-title":"J Am Geriatr Soc."},{"key":"1294_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ije\/dyr148","volume":"41","author":"JA Pasco","year":"2012","unstructured":"Pasco JA, Nicholson GC, Kotowicz MA. Cohort profile: Geelong Osteoporosis Study. Int J Epidemiol. 2012;41:1565\u201375.","journal-title":"Int J Epidemiol."},{"key":"1294_CR14","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1038\/s41598-020-67251-8","volume":"10","author":"SX Sui","year":"2020","unstructured":"Sui SX, Holloway-Kew KL, Hyde NK, Williams LJ, Leach S, Pasco JA. Muscle strength and gait speed rather than lean mass are better indicators for poor cognitive function in older men. Sci Rep. 2020;10:10367.","journal-title":"Sci Rep."},{"key":"1294_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00223-020-00759-3","volume":"108","author":"SX Sui","year":"2021","unstructured":"Sui SX, Williams LJ, Holloway-Kew KL, Hyde NK, Anderson KB, Tembo MC, et al. Skeletal muscle density and cognitive function: a cross-sectional study in men. Calcif Tissue Int. 2021;108:165\u201375.","journal-title":"Calcif Tissue Int."},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jocd.2021.03.007","volume":"25","author":"SX Sui","year":"2022","unstructured":"Sui SX, Williams LJ, Holloway-Kew KL, Hyde NK, Leach S, Pasco JA. Associations between muscle quality and cognitive function in older men: cross-sectional data from the Geelong Osteoporosis Study. J Clin Densitom. 2022;25:133\u201340.","journal-title":"J Clin Densitom."},{"key":"1294_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/jcm10020173","volume":"10","author":"JA Pasco","year":"2021","unstructured":"Pasco JA, Stuart AL, Sui SX, Holloway-Kew KL, Hyde NK, Tembo MC, et al. Dynapenia and low cognition: a cross-sectional association in postmenopausal women. J Clin Med. 2021;10:173.","journal-title":"J Clin Med."},{"key":"1294_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/practneurol-2016-001520","volume":"17","author":"E Devenney","year":"2017","unstructured":"Devenney E, Hodges JR. The Mini-Mental State Examination: pitfalls and limitations. Pract Neurol. 2017;17:79\u201380.","journal-title":"Pract Neurol."},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/0004867415614105","volume":"50","author":"LJ Williams","year":"2016","unstructured":"Williams LJ, Jacka FN, Pasco JA, Coulson CE, Quirk SE, Stuart AL, et al. The prevalence and age of onset of psychiatric disorders in Australian men. Aust N Z J Psychiatry. 2016;50:678\u201384.","journal-title":"Aust N Z J Psychiatry."},{"key":"1294_CR20","doi-asserted-by":"crossref","unstructured":"Rufus-Membere P, Holloway-Kew KL, Diez-Perez A, Kotowicz MA, Pasco JA. Associations between bone material strength index, calcaneal quantitative ultrasound, and bone mineral density in men. J Endocr Soc. 2021;5:bvaa179.","DOI":"10.1210\/jendso\/bvaa179"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12891-021-04042-w","volume":"22","author":"V Chandrasekaran","year":"2021","unstructured":"Chandrasekaran V, Pasco JA, Stuart AL, Brennan-Olsen SL, Berk M, Hodge JM, et al. Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study. BMC Musculoskelet Disord. 2021;22:172.","journal-title":"BMC Musculoskelet Disord."},{"key":"1294_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00223-015-0053-y","volume":"97","author":"JA Pasco","year":"2015","unstructured":"Pasco JA, Lane SE, Brennan-Olsen SL, Holloway KL, Timney EN, Bucki-Smith G, et al. The epidemiology of incident fracture from cradle to senescence. Calcif Tissue Int. 2015;97:568\u201376.","journal-title":"Calcif Tissue Int."},{"key":"1294_CR23","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1039\/C9AN01893J","volume":"145","author":"C Gaither","year":"2020","unstructured":"Gaither C, Popp R, Mohammed Y, Borchers CH. Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometry. Analyst. 2020;145:3634\u201344.","journal-title":"Analyst."},{"key":"1294_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17\u201323.","journal-title":"Nat Genet."},{"key":"1294_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69:1318\u201325.","journal-title":"Arch Neurol."},{"key":"1294_CR26","doi-asserted-by":"crossref","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234-W41.","DOI":"10.1093\/nar\/gkz240"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Nucleic Acids Res."},{"key":"1294_CR28","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50:D687\u201392.","journal-title":"Nucleic Acids Res."},{"key":"1294_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neurobiolaging.2015.10.037","volume":"39","author":"LM Ramirez","year":"2016","unstructured":"Ramirez LM, Goukasian N, Porat S, Hwang KS, Eastman JA, Hurtz S, et al. Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiol Aging. 2016;39:82\u20139.","journal-title":"Neurobiol Aging."},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12031-018-1045-y","volume":"64","author":"JFF Almeida","year":"2018","unstructured":"Almeida JFF, Dos Santos LR, Trancozo M, de Paula F. Updated meta-analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 variants in Alzheimer\u2019s disease. J Mol Neurosci. 2018;64:471\u20137.","journal-title":"J Mol Neurosci."},{"key":"1294_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034078","volume":"7","author":"F Song","year":"2012","unstructured":"Song F, Poljak A, Crawford J, Kochan NA, Wen W, Cameron B, et al. Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One. 2012;7: e34078.","journal-title":"PLoS One."},{"key":"1294_CR32","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 2012;79:897\u2013905.","journal-title":"Neurology."},{"issue":"799\u2013807","key":"1294_CR33","volume":"10","author":"A Hye","year":"2014","unstructured":"Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimer\u2019s Dement. 2014;10:799\u2013807.e2.","journal-title":"Alzheimer\u2019s Dement."},{"key":"1294_CR34","doi-asserted-by":"crossref","unstructured":"Johnstone D, Milward EA, Berretta R, Moscato P, Alzheimer\u2019s Disease Neuroimaging I. Multivariate protein signatures of pre-clinical Alzheimer\u2019s disease in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) plasma proteome dataset. PLoS One. 2012;7:e34341.","DOI":"10.1371\/journal.pone.0034341"},{"key":"1294_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0009-8981(95)06115-T","volume":"239","author":"M Kawano","year":"1995","unstructured":"Kawano M, Kawakami M, Otsuka M, Yashima H, Yaginuma T, Ueki A. Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer\u2019s disease. Clin Chim Acta. 1995;239:209\u201311.","journal-title":"Clin Chim Acta."},{"key":"1294_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000090676","volume":"21","author":"HC Liu","year":"2006","unstructured":"Liu HC, Hu CJ, Chang JG, Sung SM, Lee LS, Yuan RY, et al. Proteomic identification of lower apolipoprotein A-I in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2006;21:155\u201361.","journal-title":"Dement Geriatr Cogn Disord."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01294-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:33:51Z","timestamp":1700228031000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01294-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01294-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent to participate in the study, which was approved by the Human Research Ethics Committee at Barwon Health (00\/56-E7) and Deakin University (2013-320). All procedures performed were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}